NDC11 50222028091
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 50222-0280-91 | 50222-0280 |
| 50222-280-91 | 50222-280 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Anzupgo | DELGOCITINIB | LEO Pharma, Inc | a59bf36e-6f04-4b47-b385-8040c95f040c | 2026-07-10 | Warnings, Adverse reactions | 50222-280-91 50222-280 50222028091 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.